Cephalexin
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 14 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 4 | SUPPLYING |
| A-S Medication Solutions | repackager | 4 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 4 | SUPPLYING |
| Ascend Laboratories, LLC | generic | 4 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 3 | SUPPLYING |
| Preferred Pharmaceuticlas Inc. | unknown | 2 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
| Proficient Rx LP | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct. — Recalling firm: Ascend Laboratories, LLC — Nationwide in the USA.
Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct. — Recalling firm: Ascend Laboratories, LLC — Nationwide in the USA.
Labeling: Not Elsewhere Classified: Back Label states Each contains: cephalexin monohydrate, USP equivalent to 5g' on the back label instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g' — Recalling firm: Bryant Ranch Prepack, Inc. — Nationwide in the USA
Labeling: Not Elsewhere Classified: Back label states Each contains: cephalexin monohydrate, USP equivalent to 2.5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g — Recalling firm: Bryant Ranch Prepack, Inc. — Nationwide in the USA
Labeling: Not Elsewhere Classified: Front label states 100 Tablets instead of 100 ml and on the back label 'Each Tablet contains' instead of 'Each Bottle contains' No total dose per bottle listed should be 2.5 g' — Recalling firm: Bryant Ranch Prepack, Inc. — Nationwide in the USA
Labeling: Not Elsewhere Classified: Back Label states 'Each contains: cephalexin monohydrate, USP equivalent to 5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g' — Recalling firm: Bryant Ranch Prepack, Inc. — Nationwide in the USA
Labeling: Not Elsewhere Classified: Back Label states 'Each contains: cephalexin monohydrate, USP equivalent to 5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g' — Recalling firm: Bryant Ranch Prepack, Inc. — Nationwide in the USA
Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin — Recalling firm: Preferred Pharmaceuticals, Inc. — recalled product was distributed to three physicians located CA
CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit. — Recalling firm: Ascend Laboratories LLC — Nationwide in the USA
CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit. — Recalling firm: Ascend Laboratories LLC — Nationwide in the USA
Failed Impurity/Degradation Specifications — Recalling firm: Ascend Laboratories LLC — Nationwide
Failed Impurity/Degradation Specifications — Recalling firm: Ascend Laboratories LLC — Nationwide
Failed Impurity/Degradation Specifications: Unidentified impurities not complying with specifications were observed in various lots of Cephalexin FOS USP 125 mg/5 mL. — Recalling firm: Ascend Laboratories LLC — Distributed Nationwide in the USA
CGMP Deviations; presence of extraneous material in the was observed in area that is between the primary package that is heat sealed and secondary packaging (poly-woven bag) of sucrose (an excipient) used in the finished product. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to 5 wholesalers, 2 drug chains and 1 supermarket who may have further distributed the product …
